Medicare utilization — JASMIN RADHIKA DESAI (M.D.)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J1756 | Injection, iron sucrose, 1 mg | 33,000 | 50 | $0 | $5,329 |
| J0185 | Injection, aprepitant, 1 mg | 4,680 | 11 | $0 | $6,448 |
| J0897 | Injection, denosumab, 1 mg | 1,620 | 16 | $0 | $29,649 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 856 | 28 | $0 | $84 |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 760 | 15 | $0 | $4,318 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·